![](/img/cover-not-exists.png)
The novel pan-PIM kinase inhibitor, PIM447, displays dual anti-myeloma and bone protective effects, and potently synergizes with current standards of care
Paino, T., Garcia-Gomez, A., Gonzalez-Mendez, L., San Segundo, L., Hernandez-Garcia, S., Lopez-Iglesias, A.-A., Algarin, E. M., Martin-Sanchez, M., Corbacho-Gonzalez, D., Ortiz-de-Solorzano, C., CorchLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-0230
Date:
July, 2016
File:
PDF, 9.54 MB
english, 2016